BofA Global Research raises Beta Bionics price objective to $22 from $20
BBNX•BofA Global Research raised its price objective for Beta Bionics to $22 from $20.
Related News
Phillips 66 beats third-quarter profit estimates
PSX•
Rapport Therapeutics plunges on stock, convertible bond sales
RAPP•
Algonquin Power & Utilities receives neutral rating from JPMorgan, with C$9 price target
AQN•
Wells Fargo raises Twilio target price to $300 from $275
TWLO•
Labcorp Q3 revenue $3,810 million versus IBES estimate of $3,759 million
LH•